PLUS1
50.05
0.86 (1.75%)
0.86 (1.75%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AstraZeneca PLC | AZN | NASDAQ | Depository Receipt |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.86 | 1.75% | 50.05 | 07:25:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 49.19 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 50.02 | 50.04 | 0.02 | - | 2 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 247 | 39,544 | 14,751,422 | 36.15 - 64.94 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:23:05 | formt | 100 | 50.05 | USD |
AstraZeneca Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 131.40B | 2.63B | 2.63B | 22.65B | 2.52B | 0.52 | 55.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | 1.40 | 2.80% | - | - |
News AstraZeneca
| Date | Time | Source | Heading |
|---|---|---|---|
| 4/14/2021 | 02:48 | Dow Jones News | AstraZeneca's Early-Stage Lung Cancer Tagrisso Drug Approved.. |
| 4/13/2021 | 20:24 | Dow Jones News | J&J Covid-19 Vaccine Pause Spotlights Science of Rare.. |
| 4/13/2021 | 19:59 | Dow Jones News | J&J Covid-19 Vaccine Pause Spotlights Science of Rare.. |
| 4/13/2021 | 19:52 | Dow Jones News | J&J Covid-19 Vaccine Pause Spotlights Science of Rare.. |
| 4/13/2021 | 18:04 | Dow Jones News | J&J Covid-19 Vaccine Pause Spotlights Science of Rare.. |
| 4/13/2021 | 18:02 | Dow Jones News | J&J Covid-19 Vaccine Pause Spotlights Science of Rare.. |
| 4/13/2021 | 12:53 | Dow Jones News | Do J&J and AstraZeneca Vaccines Cause Blood Clots? What You.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
AZN Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales. |
